EDGAR Filing Documents for 0001193125-09-055220

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-09-055220

Filing Date

2009-03-16

Accepted

2009-03-16 14:37:59

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1928418
2	FORM OF SERIES F PREFERRED STOCK CERTIFICATE	dex48.htm	EX-4.8	6111
3	FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT	dex105.htm	EX-10.5	32264
4	FORM OF AMENDMENT TO STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT	dex106.htm	EX-10.6	17100
5	AMENDMENT TO EMPLOYMENT AGREEMENT, CRAIG PHILIPS, DATED DECEMBER 31, 2008	dex1010.htm	EX-10.10	13438
6	DIRECTOR COMPENSATION POLICY	dex1019.htm	EX-10.19	9760
7	TERMINATION OF SECURITIES PURCHASE AGREEMENT, MIDSUMMER INVESTMENT, LTD.	dex1044.htm	EX-10.44	17129
8	FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT, BIOGEN IDEC INC.	dex1048.htm	EX-10.48	12123
9	AMENDED AND RESTATED SECURITY AGREEMENT, BIOGEN IDEC INC.	dex1049.htm	EX-10.49	61299
10	STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	16693
11	SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	992
12	CONSENT OF STONEFIELD JOSEPHSON, INC.	dex231.htm	EX-23.1	1471
13	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex311.htm	EX-31.1	6840
14	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex312.htm	EX-31.2	7005
15	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER	dex32.htm	EX-32	6126
16	GRAPHIC	g34346g83v40.jpg	GRAPHIC	63354
	Complete submission text file	0001193125-09-055220.txt		2225620

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)